av/astrazeneca--big.svg

NSE:ASTRAZEN

AstraZeneca Pharma India Limited

  • Stock

INR

Last Close

6,939.65

26/07 09:59

Market Cap

171.96B

Beta: 0.39

Volume Today

65.72K

Avg: 4.82K

PE Ratio

108.89

PFCF: 7,021.31

Dividend Yield

0.24%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
4.74B
-
4.69B
0.99%
5.26B
12.24%
5.40B
2.49%
5.71B
5.82%
7.28B
27.54%
8.32B
14.22%
8.09B
2.79%
8.06B
0.37%
10.03B
24.50%
12.96B
29.17%
cost of revenue
1.80B
-
2.03B
12.65%
2.13B
4.86%
2.02B
5.15%
2.24B
10.75%
2.70B
20.61%
3.34B
24.01%
3.31B
1.15%
3.57B
8.14%
4.58B
28.04%
8.51B
85.92%
gross profit
2.94B
-
2.66B
9.37%
3.14B
17.87%
3.38B
7.67%
3.47B
2.88%
4.59B
31.99%
4.97B
8.46%
4.78B
3.90%
4.48B
6.25%
5.45B
21.68%
4.45B
18.47%
selling and marketing expenses
454.97M
-
666.19M
46.43%
728.16M
9.30%
544.11M
25.28%
728.10M
33.82%
798M
9.60%
557.60M
30.13%
452.10M
18.92%
507.20M
12.19%
597.42M
17.79%
general and administrative expenses
172.18M
-
176.87M
2.72%
160.98M
8.98%
164.95M
2.47%
124.20M
24.70%
235.70M
89.77%
273.50M
16.04%
271.10M
0.88%
247.50M
8.71%
299.30M
20.93%
selling general and administrative expenses
627.15M
-
843.06M
34.43%
889.14M
5.47%
709.06M
20.25%
852.30M
20.20%
1.03B
21.28%
831.10M
19.60%
723.20M
12.98%
754.70M
4.36%
597.42M
20.84%
2.75B
360.43%
research and development expenses
227M
-
287.60M
26.70%
391.90M
36.27%
591.60M
50.96%
other expenses
10.39M
-
6.72M
35.35%
9.45M
40.72%
3.96M
58.12%
4.80M
21.28%
2M
58.33%
3.12B
155,765%
2.89B
7.15%
3.03B
4.69%
4.34B
43.35%
cost and expenses
4.97B
-
4.92B
0.92%
5.27B
7.11%
5.12B
2.89%
5.37B
4.88%
6.72B
25.14%
7.29B
8.54%
6.92B
5.06%
7.36B
6.31%
9.52B
29.33%
11.26B
18.30%
operating expenses
3.17B
-
2.89B
8.64%
3.14B
8.69%
3.10B
1.36%
3.13B
1.05%
4.02B
28.38%
3.95B
1.84%
3.62B
8.38%
3.78B
4.62%
4.94B
30.55%
2.75B
44.33%
interest expense
11.40M
-
10.90M
4.39%
9.50M
12.84%
6.33M
33.35%
12.01M
89.62%
ebitda
-291.00M
-
-47.33M
83.73%
166.98M
452.77%
439.14M
162.99%
506.90M
15.43%
712.40M
40.54%
1.33B
87.25%
1.46B
9.55%
984.10M
32.66%
1.11B
12.56%
1.84B
66.52%
operating income
-225.97M
-
-262.61M
16.21%
-6.87M
97.38%
196.70M
2,964.22%
341.30M
73.51%
563.80M
65.19%
1.15B
103.65%
1.26B
10.08%
814.60M
35.55%
945.09M
16.02%
1.70B
79.36%
depreciation and amortization
101.25M
-
152.81M
50.93%
174.26M
14.04%
158.26M
9.18%
147.40M
6.86%
149.20M
1.22%
185.80M
24.53%
197.50M
6.30%
169.50M
14.18%
162.60M
4.07%
149.41M
8.12%
total other income expenses net
54.21M
-
64.50M
18.99%
135.35M
109.83%
96.70M
28.55%
162.90M
68.46%
-8.50M
105.22%
7M
182.35%
15.80M
125.71%
395.96M
2,406.07%
500.26M
26.34%
income before tax
-208.40M
-
57.64M
127.66%
332.05M
476.11%
438M
31.91%
726.70M
65.91%
1.14B
56.83%
1.27B
11.51%
830.40M
34.66%
1.34B
61.49%
2.20B
63.70%
income tax expense
5.09M
-
62.46M
1,127.28%
5.05M
91.92%
87.63M
1,636.34%
178.90M
104.16%
182.20M
1.84%
417.60M
129.20%
337.90M
19.09%
214.40M
36.55%
348.12M
62.37%
580.26M
66.68%
net income
-5.09M
-
-208.40M
3,994.91%
52.59M
125.24%
244.42M
364.77%
259.10M
6.00%
544.50M
110.15%
722.10M
32.62%
933M
29.21%
616M
33.98%
992.90M
61.19%
1.62B
62.66%
weighted average shs out
25M
-
25M
0%
25M
0%
25M
0%
25M
0%
25M
0%
25M
0%
25M
0%
25M
0%
25M
0%
25.00M
0.00%
weighted average shs out dil
25M
-
25M
0%
25M
0%
25M
0%
25M
0%
25M
0%
25M
0%
25M
0%
25M
0%
25M
0%
25.00M
0.00%
eps
-0.20
-
-8.34
4,070.00%
2.10
125.18%
8
280.95%
10.36
29.50%
21.78
110.23%
28.88
32.60%
37.32
29.22%
24.64
33.98%
39.72
61.20%
64.60
62.64%
epsdiluted
-0.20
-
-8.34
4,070.00%
2.10
125.18%
8
280.95%
10.36
29.50%
21.78
110.23%
28.88
32.60%
37.32
29.22%
24.64
33.98%
39.72
61.20%
64.60
62.64%

All numbers in INR (except ratios and percentages)